Skip to main content

Volume 10 Supplement 1

Proceedings of the Seventh Scientific Meeting of The TMJ Association

  • Poster presentation
  • Open access
  • Published:

Repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex for treating facial neuropathic pain – preliminary results of a randomized, sham-controlled, cross-over study


Repetitive transcranial magnetic stimulation (rTMS) noninvasively triggers action potentials in underlying brain cortex intended for therapeutic benefit. Currently marketed for refractory depression, rTMS is under investigation for treating several neurological conditions including pain. Facial neuropathic pain (NP) appears to respond well to rTMS [1]. The primary motor cortex (M1) is established as the best site to stimulate to relieve pain, but the best target within M1 remains unknown [1, 2]. MRI guidance of rTMS permits repeated precise application to specific targets. The aim of this study was to compare pain relief obtained by applying MRI-guided rTMS to the M1 representation of subjects’ painful face vs. to adjacent M1 cortex innervating their non-painful hand.

Materials and methods

In this ongoing randomized, single-blinded, placebo-controlled, cross-over study, eight adults with facial NP provided informed consent for head MRI and rTMS. Subjects undertook the 3 study phases in random order. In one phase, rTMS was applied to the contralateral M1 representation of their painful face. In the others, rTMS was applied to the adjacent hand area, or sham-rTMS was administered to the hand area using a spacer below the coil. In each phase, 1500 stimuli were administered using a Nexstim NBS 3.2 with a double 70mm coil. Five-second trains of 10 Hz pulses were applied at 80% of resting motor threshold with 55 second inter-train intervals. Each study-phase involved recording baseline data for 3 days, 5 consecutive daily sessions of rTMS, followed by 3 washout weeks. The primary outcome was change in the 0-10 numeric pain rating score. Secondary outcomes measured physical and mental functioning using the SF-36, McGill pain questionnaire and Beck depression Inventory.


Among the 8 subjects studied so far, 4 had V1 postherpetic neuralgia, 2 had ocular NP, and one each had trigeminal neuralgia and idiopathic facial pain. Reductions in mean pain intensity were >20% on treatment days 3-5 during both active treatments, but not during sham treatment. Pain reverted to baseline within two weeks after ending treatment. 3/8 subjects had pain reductions >30% when the cortex innervating their hand was stimulated and 2/8 had reductions >30% when cortex innervating their face was stimulated. Secondary outcomes did not change and there were no significant adverse events.


These preliminary results corroborate the efficacy of rTMS for facial NP. Recruitment is ongoing to test the hypothesis that stimulating adjacent healthy cortex may relieve pain better than stimulating cortex representing the painful face [3].


None of the authors have any conflicts of interest to disclose.


  1. O'Connell NE, Wand BM, Marston L, Spencer S, DeSouza LH: Non-invasive brain stimulation techniques for chronic pain. Cochrane.Database.Syst.Rev 2014, 4: CD008208.

    PubMed  Google Scholar 

  2. Leung A, Donohue M, Xu R, Lee R, Lefaucheur JP, Khedr EM, et al.: rTMS for suppressing neuropathic pain: a meta-analysis. J.Pain 2009, 10: 1205–1216. 10.1016/j.jpain.2009.03.010

    Article  PubMed  Google Scholar 

  3. Lefaucheur JP, Drouot X, Menard-Lefaucheur I, Zerah F, Bendib B, Cesaro P, et al.: Neurogenic pain relief by repetitive transcranial magnetic cortical stimulation depends on the origin and the site of pain. Journal of Neurology, Neurosurgery & Psychiatry 2004, 75: 612–616. 10.1136/jnnp.2003.022236

    Article  Google Scholar 

Download references


The authors contributed equally. Research supported in part by the U.S. NIH (NINDS K24NS059892) and donations from the Bradley, Collman, and Samuels family foundations.

Author information

Authors and Affiliations


Additional information

Magdalena Lang, Roi Treister contributed equally to this work.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lang, M., Treister, R., Klein, M. et al. Repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex for treating facial neuropathic pain – preliminary results of a randomized, sham-controlled, cross-over study. Mol Pain 10 (Suppl 1), P6 (2014).

Download citation

  • Published:

  • DOI: